Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Seres Theraptc (NQ: MCRB )

25.52 USD +0.39 (+1.53%)
Streaming Delayed Price Updated: 3:08 PM EST, Dec 3, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 401,637
Open 25.20
Bid (Size) 25.48 (1)
Ask (Size) 25.55 (1)
Prev. Close 25.13
Today's Range 25.18 - 26.10
52wk Range 2.520 - 38.50
Shares Outstanding 40,652,668
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences
Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced that management will participate in two upcoming investor conferences: 
From Business Wire News Releases
Seres Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
Seres Therapeutics, Inc., (Nasdaq: MCRB) today reported financial results from the third quarter ended September 30, 2020, and provided business updates. 
From Business Wire News Releases

Performance

YTD
+661.64%
+661.64%
1 Month
-13.54%
-13.54%
3 Month
-0.49%
-0.49%
6 Month
+407.26%
+407.26%
1 Year
+580.40%
+580.40%

More News

Read More
Seres Therapeutics Announces Initiation of Phase 1b Trial of SER-301 for the Treatment of Ulcerative Colitis
From Business Wire News Releases
Seres Therapeutics to Host Third Quarter 2020 Financial Results and Operational Progress Conference Call and Webcast on November 9, 2020
From Business Wire News Releases
Seres Therapeutics Expands Executive Team with Appointments of David S. Ege, Ph.D., as Chief Technology Officer and Jayne M. Gansler as Chief People Officer
From Business Wire News Releases
Noteworthy Tuesday Option Activity: MCRB, LORL, MEG
Tags Stocks
From Market News Video
Seres Therapeutics to Present SER-109 Phase 3 ECOSPOR III Study Results at American College of Gastroenterology Annual Scientific Meeting
From Business Wire News Releases
Seres Therapeutics to Present at the Jefferies Next Generation IBD Therapeutics Summit
From Business Wire News Releases
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway
Tags PSTV PRPO ENTX
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Tags ARCB Consumer Discretionary PTCT
From Benzinga
The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted
Tags KYMR INSM ALXO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.